One Drop Announces Launch Of SugarRx

NEW YORK, April 8, 2020 /PRNewswire/ — One Drop, a leader in digital therapeutics solutions for people living with diabetes and other chronic conditions, today announced the launch of SugarRx, a digital subscription for personal diabetes coaching and education, delivered entirely in the award-winning One Drop app.

SugarRx is an immersive educational experience and represents an evolution of One Drop’s ADA-recognized coaching platform (formerly “One Drop | Experts”). Grounded in behavioral science, SugarRx combines interactive modules with empirically established techniques that motivate and support behavior change. For example, SugarRx delivers in-app prompts for commitment, social- and self-reward, and normative messaging. Users are also tasked with goal setting, challenged to solve problems, and encouraged to build a therapeutic relationship with their coach.

“Realizing long-term behavior change is hard, but One Drop makes it easier,” said One Drop VP of Behavioral Design & Science, Dr. Gina Merchant. “Unlike many consumer-facing platforms, SugarRx goes beyond basic self-tracking and generic feedback. Instead, our new digital offering leverages not only behavioral science, but also predictive analytics and data science to deliver a highly engaging and effective experience that sparks sustainable behavior change.”

In addition to evidence-based content and tools, SugarRx gives users on-demand access to a personal health coach. Every One Drop coach is a Diabetes Care and Education Specialist with years of experience helping people manage their diabetes and improve their health. Subscribers can message their coach anytime for answers, advice, and encouragement—without an appointment and from the comfort of home.

SugarRx is supplemented by AI-powered glucose predictions, alerting users to a sharp drop or unexpected rise in blood sugar levels ahead of time. One Drop pairs glucose predictions with actionable real-time advice, helping users make informed choices about their health or seek additional help to prevent problems. All data recorded in the app is available to coaches, allowing them to provide personalized behavioral guidance.

One Drop offers memberships to digital coaching and educational resources for people living with diabetes, prediabetes, high blood pressure, high cholesterol, or a combination of these conditions. One Drop’s enterprise program provides an end-to-end solution for employers who want to reduce healthcare costs and give their eligible employees the tools, data, and support they need to make positive changes in their health. The company’s unique approach combines personal health coaching with AI-powered Predictive Insights to inspire positive behavior change and deliver affordable, effective care to the greatest number of people possible.

About One Drop
One Drop is a digital health company harnessing the power of data science and mobile computing to transform the lives of people with diabetes and other chronic conditions worldwide. Its evidence-based platform offers affordable, accessible care to individuals, employers, insurers, and healthcare providers. One Drop leverages proprietary machine learning, advanced AI, and personal health coaching to deliver customized programs that promote positive behavior change and drive outcomes.

For information on helping your organization lower the cost of care for diabetes, prediabetes, hypertension, or high cholesterol, contact results@onedrop.today.

One Drop’s consumer services are available for purchase in One Drop’s award-winning app (iOS and Android), and in the Apple Store, as well as at One Drop’s website, Walmart, Amazon, and BestBuy.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/one-drop-announces-launch-of-sugarrx-301037312.html

SOURCE One Drop

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

1 hour ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

1 hour ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

2 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

2 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

2 hours ago